Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 28-sep-2026 · last seen 28-sep-2026

Hematopoietic Stem Cell Aging (BIRC6 Axis)

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-09-23 — Targeting BIRC6 rejuvenates hematopoietic stem cell aging and immunosenescence.: 2026 preclinical study maps a BM Treg → cAMP → PKA → CREB → BIRC6 axis that expands apoptosis-resistant aged HSCs; antibody-conjugated LNP-ASO BIRC6 inhibition rejuvenates hematopoietic output and immune function in middle-aged mice with activity confirmed in middle-aged human HSCs ex vivo — first mechanism-plus-targeted-intervention entry for this page, still fully preclinical. [animal-model] (novelty: 4)

Open questions

Related

Contributing findings

pubmed preclinical animal-model
Targeting BIRC6 rejuvenates hematopoietic stem cell aging and immunosenescence.
23-sep-2026 novelty 4 per-area 4 strengthens

build build 880 · 2bcef25 · 2026-11-18